Abstract

BackgroundThe objective of the present study was to identify human epididymis protein 4 (HE4) interacting proteins and explore the mechanisms underlying their effect on ovarian cancer cell invasion and metastasis.MethodsHE4 interacting proteins were identified by mass spectrometry and validated by co-immunoprecipitation and pull-down assays. The scratch test, the Transwell assay and animal experiments were used to assess the invasive and metastatic abilities of ovarian cancer cells before and after transfection and HE4 protein treatment. HE4 and annexin II protein expression in epithelial ovarian tissues was detected by immunohistochemistry, and the relation between their expression levels was examined.ResultsAnnexin II was identified as an HE4 interacting protein. HE4 and annexin II binding interaction promoted ovarian cancer cell invasion and metastasis. HE4 and annexin II expression levels were significantly higher in malignant epithelial ovarian tissues than in benign and normal epithelial ovarian tissues, and they were higher in tissues with lymph node metastases than in those without. HE4 gene interference downregulated the expression of MAPK and the FOCAL adhesion signaling pathway-associated molecules MKNK2 and LAMB2, and HE4 protein supplementation reversed this effect.ConclusionThe binding interaction between HE4 and annexin II activates the MAPK and FOCAL adhesion signaling pathways, promoting ovarian cancer cell invasion and metastasis.Electronic supplementary materialThe online version of this article (doi:10.1186/1476-4598-13-243) contains supplementary material, which is available to authorized users.

Highlights

  • The objective of the present study was to identify human epididymis protein 4 (HE4) interacting proteins and explore the mechanisms underlying their effect on ovarian cancer cell invasion and metastasis

  • We showed that annexin II (ANXA2), a specific binding partner of HE4, is expressed in ovarian cancer cells, and the interaction between HE4 and Annexin II (ANXA2) promotes the invasion and metastasis of ovarian cancer cells via the MAPK and FOCAL signaling pathways

  • Our findings indicated that MAP kinase interacting serine/threonine kinase 2 (MKNK2) and laminin beta 2 (LAMB2) gene expression levels were downregulated in response to HE4 interference in ovarian cancer cells, whereas exogenous HE4 protein supplementation reversed this effect

Read more

Summary

Introduction

The objective of the present study was to identify human epididymis protein 4 (HE4) interacting proteins and explore the mechanisms underlying their effect on ovarian cancer cell invasion and metastasis. Elucidating the mechanisms underlying the development and progression of ovarian cancer at a molecular level is important to facilitate the early diagnosis and treatment of ovarian cancer and to improve the prognosis of patients with this disease. Recent studies showed that HE4 mainly affects the invasive and metastatic ability of ovarian cancer cells [8,9]; the underlying mechanism remains unclear. Whether HE4 acts alone or through interaction with a receptor on the cell membrane to affect the malignant biological behavior of ovarian cancer cells remains unknown

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call